Vassilev, Alexei O

Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors. [electronic resource] - Current drug targets Mar 2006 - 327-43 p. digital

Publication Type: Journal Article; Review

1389-4501

10.2174/138945006776054997 doi


Agammaglobulinaemia Tyrosine Kinase
Animals
Autoimmune Diseases--drug therapy
Diabetes Mellitus, Type 1--drug therapy
Drug Delivery Systems
Drug Design
Enzyme Inhibitors--pharmacology
Humans
Janus Kinase 3
Neoplasms--complications
Organ Transplantation--physiology
Protein-Tyrosine Kinases--antagonists & inhibitors